Fournier's Gangrene and Sodium-glucose Co-transporter 2(SGLT2) Inhibitors: Our Experience

Схожие документы

• Fournier’s Gangrene and Diabetic Ketoacidosis Associated with Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: Life-Threatening Complications
  по: Kasbawala, Kinjal, et al.
  Опубликовано: (2020)
• Bitter sweet: Fournier’s Gangrene and SGLT2 inhibitors
  по: Coralea Kappel
  Опубликовано: (2019-12-01)
• Real-world evidence on sodium-glucose cotransporter-2 inhibitor use and risk of Fournier’s gangrene
  по: Yang, Jeff Yufeng, et al.
  Опубликовано: (2020)
• Association of Sodium-Glucose Cotransporter 2 Inhibitor Treatment With Risk of Hospitalization for Fournier Gangrene Among Men
  по: Dave, Chintan V., et al.
  Опубликовано: (2019)
• Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors: A Review of Their Basic and Clinical Pharmacology
  по: Kalra, Sanjay
  Опубликовано: (2014)